Global IL-17 Targeting Biological Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global IL-17 Targeting Biological Drugs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
IL-17 (interleukin-17) is an important pro-inflammatory cytokine that plays an important role in the pathological process of autoimmune diseases such as psoriasis and rheumatoid arthritis. Biological drugs targeting IL-17 reduce inflammatory responses and disease symptoms by inhibiting the activity of IL-17 or its receptors.
This report is a detailed and comprehensive analysis for global IL-17 Targeting Biological Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global IL-17 Targeting Biological Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global IL-17 Targeting Biological Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global IL-17 Targeting Biological Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global IL-17 Targeting Biological Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for IL-17 Targeting Biological Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global IL-17 Targeting Biological Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chongqing Genrix Biopharmaceutical, Jiangsu Hengrui Medicine, Novartis, UCB, Eli Lilly and Co., Akesobio, AstraZeneca, DICE Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
IL-17 Targeting Biological Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe IL-17 Targeting Biological Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of IL-17 Targeting Biological Drugs, with price, sales quantity, revenue, and global market share of IL-17 Targeting Biological Drugs from 2021 to 2026.
Chapter 3, the IL-17 Targeting Biological Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IL-17 Targeting Biological Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and IL-17 Targeting Biological Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of IL-17 Targeting Biological Drugs.
Chapter 14 and 15, to describe IL-17 Targeting Biological Drugs sales channel, distributors, customers, research findings and conclusion.
IL-17 (interleukin-17) is an important pro-inflammatory cytokine that plays an important role in the pathological process of autoimmune diseases such as psoriasis and rheumatoid arthritis. Biological drugs targeting IL-17 reduce inflammatory responses and disease symptoms by inhibiting the activity of IL-17 or its receptors.
This report is a detailed and comprehensive analysis for global IL-17 Targeting Biological Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global IL-17 Targeting Biological Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global IL-17 Targeting Biological Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global IL-17 Targeting Biological Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global IL-17 Targeting Biological Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for IL-17 Targeting Biological Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global IL-17 Targeting Biological Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chongqing Genrix Biopharmaceutical, Jiangsu Hengrui Medicine, Novartis, UCB, Eli Lilly and Co., Akesobio, AstraZeneca, DICE Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
IL-17 Targeting Biological Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Oral
- Injection
- Hospital
- Clinic
- Other
- Chongqing Genrix Biopharmaceutical
- Jiangsu Hengrui Medicine
- Novartis
- UCB
- Eli Lilly and Co.
- Akesobio
- AstraZeneca
- DICE Therapeutics
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe IL-17 Targeting Biological Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of IL-17 Targeting Biological Drugs, with price, sales quantity, revenue, and global market share of IL-17 Targeting Biological Drugs from 2021 to 2026.
Chapter 3, the IL-17 Targeting Biological Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IL-17 Targeting Biological Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and IL-17 Targeting Biological Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of IL-17 Targeting Biological Drugs.
Chapter 14 and 15, to describe IL-17 Targeting Biological Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global IL-17 Targeting Biological Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Oral
1.3.3 Injection
1.4 Market Analysis by Application
1.4.1 Overview: Global IL-17 Targeting Biological Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global IL-17 Targeting Biological Drugs Market Size & Forecast
1.5.1 Global IL-17 Targeting Biological Drugs Consumption Value (2021 & 2025 & 2032)
1.5.2 Global IL-17 Targeting Biological Drugs Sales Quantity (2021-2032)
1.5.3 Global IL-17 Targeting Biological Drugs Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Chongqing Genrix Biopharmaceutical
2.1.1 Chongqing Genrix Biopharmaceutical Details
2.1.2 Chongqing Genrix Biopharmaceutical Major Business
2.1.3 Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product and Services
2.1.4 Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Chongqing Genrix Biopharmaceutical Recent Developments/Updates
2.2 Jiangsu Hengrui Medicine
2.2.1 Jiangsu Hengrui Medicine Details
2.2.2 Jiangsu Hengrui Medicine Major Business
2.2.3 Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product and Services
2.2.4 Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Jiangsu Hengrui Medicine Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis IL-17 Targeting Biological Drugs Product and Services
2.3.4 Novartis IL-17 Targeting Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Novartis Recent Developments/Updates
2.4 UCB
2.4.1 UCB Details
2.4.2 UCB Major Business
2.4.3 UCB IL-17 Targeting Biological Drugs Product and Services
2.4.4 UCB IL-17 Targeting Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 UCB Recent Developments/Updates
2.5 Eli Lilly and Co.
2.5.1 Eli Lilly and Co. Details
2.5.2 Eli Lilly and Co. Major Business
2.5.3 Eli Lilly and Co. IL-17 Targeting Biological Drugs Product and Services
2.5.4 Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Eli Lilly and Co. Recent Developments/Updates
2.6 Akesobio
2.6.1 Akesobio Details
2.6.2 Akesobio Major Business
2.6.3 Akesobio IL-17 Targeting Biological Drugs Product and Services
2.6.4 Akesobio IL-17 Targeting Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Akesobio Recent Developments/Updates
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca IL-17 Targeting Biological Drugs Product and Services
2.7.4 AstraZeneca IL-17 Targeting Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 AstraZeneca Recent Developments/Updates
2.8 DICE Therapeutics
2.8.1 DICE Therapeutics Details
2.8.2 DICE Therapeutics Major Business
2.8.3 DICE Therapeutics IL-17 Targeting Biological Drugs Product and Services
2.8.4 DICE Therapeutics IL-17 Targeting Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 DICE Therapeutics Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IL-17 TARGETING BIOLOGICAL DRUGS BY MANUFACTURER
3.1 Global IL-17 Targeting Biological Drugs Sales Quantity by Manufacturer (2021-2026)
3.2 Global IL-17 Targeting Biological Drugs Revenue by Manufacturer (2021-2026)
3.3 Global IL-17 Targeting Biological Drugs Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of IL-17 Targeting Biological Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 IL-17 Targeting Biological Drugs Manufacturer Market Share in 2025
3.4.3 Top 6 IL-17 Targeting Biological Drugs Manufacturer Market Share in 2025
3.5 IL-17 Targeting Biological Drugs Market: Overall Company Footprint Analysis
3.5.1 IL-17 Targeting Biological Drugs Market: Region Footprint
3.5.2 IL-17 Targeting Biological Drugs Market: Company Product Type Footprint
3.5.3 IL-17 Targeting Biological Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global IL-17 Targeting Biological Drugs Market Size by Region
4.1.1 Global IL-17 Targeting Biological Drugs Sales Quantity by Region (2021-2032)
4.1.2 Global IL-17 Targeting Biological Drugs Consumption Value by Region (2021-2032)
4.1.3 Global IL-17 Targeting Biological Drugs Average Price by Region (2021-2032)
4.2 North America IL-17 Targeting Biological Drugs Consumption Value (2021-2032)
4.3 Europe IL-17 Targeting Biological Drugs Consumption Value (2021-2032)
4.4 Asia-Pacific IL-17 Targeting Biological Drugs Consumption Value (2021-2032)
4.5 South America IL-17 Targeting Biological Drugs Consumption Value (2021-2032)
4.6 Middle East & Africa IL-17 Targeting Biological Drugs Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2032)
5.2 Global IL-17 Targeting Biological Drugs Consumption Value by Type (2021-2032)
5.3 Global IL-17 Targeting Biological Drugs Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2032)
6.2 Global IL-17 Targeting Biological Drugs Consumption Value by Application (2021-2032)
6.3 Global IL-17 Targeting Biological Drugs Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2032)
7.2 North America IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2032)
7.3 North America IL-17 Targeting Biological Drugs Market Size by Country
7.3.1 North America IL-17 Targeting Biological Drugs Sales Quantity by Country (2021-2032)
7.3.2 North America IL-17 Targeting Biological Drugs Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2032)
8.2 Europe IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2032)
8.3 Europe IL-17 Targeting Biological Drugs Market Size by Country
8.3.1 Europe IL-17 Targeting Biological Drugs Sales Quantity by Country (2021-2032)
8.3.2 Europe IL-17 Targeting Biological Drugs Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific IL-17 Targeting Biological Drugs Market Size by Region
9.3.1 Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific IL-17 Targeting Biological Drugs Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2032)
10.2 South America IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2032)
10.3 South America IL-17 Targeting Biological Drugs Market Size by Country
10.3.1 South America IL-17 Targeting Biological Drugs Sales Quantity by Country (2021-2032)
10.3.2 South America IL-17 Targeting Biological Drugs Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa IL-17 Targeting Biological Drugs Market Size by Country
11.3.1 Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa IL-17 Targeting Biological Drugs Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 IL-17 Targeting Biological Drugs Market Drivers
12.2 IL-17 Targeting Biological Drugs Market Restraints
12.3 IL-17 Targeting Biological Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of IL-17 Targeting Biological Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of IL-17 Targeting Biological Drugs
13.3 IL-17 Targeting Biological Drugs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 IL-17 Targeting Biological Drugs Typical Distributors
14.3 IL-17 Targeting Biological Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global IL-17 Targeting Biological Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Oral
1.3.3 Injection
1.4 Market Analysis by Application
1.4.1 Overview: Global IL-17 Targeting Biological Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global IL-17 Targeting Biological Drugs Market Size & Forecast
1.5.1 Global IL-17 Targeting Biological Drugs Consumption Value (2021 & 2025 & 2032)
1.5.2 Global IL-17 Targeting Biological Drugs Sales Quantity (2021-2032)
1.5.3 Global IL-17 Targeting Biological Drugs Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Chongqing Genrix Biopharmaceutical
2.1.1 Chongqing Genrix Biopharmaceutical Details
2.1.2 Chongqing Genrix Biopharmaceutical Major Business
2.1.3 Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product and Services
2.1.4 Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Chongqing Genrix Biopharmaceutical Recent Developments/Updates
2.2 Jiangsu Hengrui Medicine
2.2.1 Jiangsu Hengrui Medicine Details
2.2.2 Jiangsu Hengrui Medicine Major Business
2.2.3 Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product and Services
2.2.4 Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Jiangsu Hengrui Medicine Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis IL-17 Targeting Biological Drugs Product and Services
2.3.4 Novartis IL-17 Targeting Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Novartis Recent Developments/Updates
2.4 UCB
2.4.1 UCB Details
2.4.2 UCB Major Business
2.4.3 UCB IL-17 Targeting Biological Drugs Product and Services
2.4.4 UCB IL-17 Targeting Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 UCB Recent Developments/Updates
2.5 Eli Lilly and Co.
2.5.1 Eli Lilly and Co. Details
2.5.2 Eli Lilly and Co. Major Business
2.5.3 Eli Lilly and Co. IL-17 Targeting Biological Drugs Product and Services
2.5.4 Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Eli Lilly and Co. Recent Developments/Updates
2.6 Akesobio
2.6.1 Akesobio Details
2.6.2 Akesobio Major Business
2.6.3 Akesobio IL-17 Targeting Biological Drugs Product and Services
2.6.4 Akesobio IL-17 Targeting Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Akesobio Recent Developments/Updates
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca IL-17 Targeting Biological Drugs Product and Services
2.7.4 AstraZeneca IL-17 Targeting Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 AstraZeneca Recent Developments/Updates
2.8 DICE Therapeutics
2.8.1 DICE Therapeutics Details
2.8.2 DICE Therapeutics Major Business
2.8.3 DICE Therapeutics IL-17 Targeting Biological Drugs Product and Services
2.8.4 DICE Therapeutics IL-17 Targeting Biological Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 DICE Therapeutics Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IL-17 TARGETING BIOLOGICAL DRUGS BY MANUFACTURER
3.1 Global IL-17 Targeting Biological Drugs Sales Quantity by Manufacturer (2021-2026)
3.2 Global IL-17 Targeting Biological Drugs Revenue by Manufacturer (2021-2026)
3.3 Global IL-17 Targeting Biological Drugs Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of IL-17 Targeting Biological Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 IL-17 Targeting Biological Drugs Manufacturer Market Share in 2025
3.4.3 Top 6 IL-17 Targeting Biological Drugs Manufacturer Market Share in 2025
3.5 IL-17 Targeting Biological Drugs Market: Overall Company Footprint Analysis
3.5.1 IL-17 Targeting Biological Drugs Market: Region Footprint
3.5.2 IL-17 Targeting Biological Drugs Market: Company Product Type Footprint
3.5.3 IL-17 Targeting Biological Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global IL-17 Targeting Biological Drugs Market Size by Region
4.1.1 Global IL-17 Targeting Biological Drugs Sales Quantity by Region (2021-2032)
4.1.2 Global IL-17 Targeting Biological Drugs Consumption Value by Region (2021-2032)
4.1.3 Global IL-17 Targeting Biological Drugs Average Price by Region (2021-2032)
4.2 North America IL-17 Targeting Biological Drugs Consumption Value (2021-2032)
4.3 Europe IL-17 Targeting Biological Drugs Consumption Value (2021-2032)
4.4 Asia-Pacific IL-17 Targeting Biological Drugs Consumption Value (2021-2032)
4.5 South America IL-17 Targeting Biological Drugs Consumption Value (2021-2032)
4.6 Middle East & Africa IL-17 Targeting Biological Drugs Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2032)
5.2 Global IL-17 Targeting Biological Drugs Consumption Value by Type (2021-2032)
5.3 Global IL-17 Targeting Biological Drugs Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2032)
6.2 Global IL-17 Targeting Biological Drugs Consumption Value by Application (2021-2032)
6.3 Global IL-17 Targeting Biological Drugs Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2032)
7.2 North America IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2032)
7.3 North America IL-17 Targeting Biological Drugs Market Size by Country
7.3.1 North America IL-17 Targeting Biological Drugs Sales Quantity by Country (2021-2032)
7.3.2 North America IL-17 Targeting Biological Drugs Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2032)
8.2 Europe IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2032)
8.3 Europe IL-17 Targeting Biological Drugs Market Size by Country
8.3.1 Europe IL-17 Targeting Biological Drugs Sales Quantity by Country (2021-2032)
8.3.2 Europe IL-17 Targeting Biological Drugs Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific IL-17 Targeting Biological Drugs Market Size by Region
9.3.1 Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific IL-17 Targeting Biological Drugs Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2032)
10.2 South America IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2032)
10.3 South America IL-17 Targeting Biological Drugs Market Size by Country
10.3.1 South America IL-17 Targeting Biological Drugs Sales Quantity by Country (2021-2032)
10.3.2 South America IL-17 Targeting Biological Drugs Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa IL-17 Targeting Biological Drugs Market Size by Country
11.3.1 Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa IL-17 Targeting Biological Drugs Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 IL-17 Targeting Biological Drugs Market Drivers
12.2 IL-17 Targeting Biological Drugs Market Restraints
12.3 IL-17 Targeting Biological Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of IL-17 Targeting Biological Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of IL-17 Targeting Biological Drugs
13.3 IL-17 Targeting Biological Drugs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 IL-17 Targeting Biological Drugs Typical Distributors
14.3 IL-17 Targeting Biological Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global IL-17 Targeting Biological Drugs Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global IL-17 Targeting Biological Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Chongqing Genrix Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Chongqing Genrix Biopharmaceutical Major Business
Table 5. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product and Services
Table 6. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Chongqing Genrix Biopharmaceutical Recent Developments/Updates
Table 8. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 9. Jiangsu Hengrui Medicine Major Business
Table 10. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product and Services
Table 11. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis IL-17 Targeting Biological Drugs Product and Services
Table 16. Novartis IL-17 Targeting Biological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Novartis Recent Developments/Updates
Table 18. UCB Basic Information, Manufacturing Base and Competitors
Table 19. UCB Major Business
Table 20. UCB IL-17 Targeting Biological Drugs Product and Services
Table 21. UCB IL-17 Targeting Biological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. UCB Recent Developments/Updates
Table 23. Eli Lilly and Co. Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly and Co. Major Business
Table 25. Eli Lilly and Co. IL-17 Targeting Biological Drugs Product and Services
Table 26. Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Eli Lilly and Co. Recent Developments/Updates
Table 28. Akesobio Basic Information, Manufacturing Base and Competitors
Table 29. Akesobio Major Business
Table 30. Akesobio IL-17 Targeting Biological Drugs Product and Services
Table 31. Akesobio IL-17 Targeting Biological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Akesobio Recent Developments/Updates
Table 33. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 34. AstraZeneca Major Business
Table 35. AstraZeneca IL-17 Targeting Biological Drugs Product and Services
Table 36. AstraZeneca IL-17 Targeting Biological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. AstraZeneca Recent Developments/Updates
Table 38. DICE Therapeutics Basic Information, Manufacturing Base and Competitors
Table 39. DICE Therapeutics Major Business
Table 40. DICE Therapeutics IL-17 Targeting Biological Drugs Product and Services
Table 41. DICE Therapeutics IL-17 Targeting Biological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. DICE Therapeutics Recent Developments/Updates
Table 43. Global IL-17 Targeting Biological Drugs Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 44. Global IL-17 Targeting Biological Drugs Revenue by Manufacturer (2021-2026) & (USD Million)
Table 45. Global IL-17 Targeting Biological Drugs Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 46. Market Position of Manufacturers in IL-17 Targeting Biological Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 47. Head Office and IL-17 Targeting Biological Drugs Production Site of Key Manufacturer
Table 48. IL-17 Targeting Biological Drugs Market: Company Product Type Footprint
Table 49. IL-17 Targeting Biological Drugs Market: Company Product Application Footprint
Table 50. IL-17 Targeting Biological Drugs New Market Entrants and Barriers to Market Entry
Table 51. IL-17 Targeting Biological Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global IL-17 Targeting Biological Drugs Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 53. Global IL-17 Targeting Biological Drugs Sales Quantity by Region (2021-2026) & (K Units)
Table 54. Global IL-17 Targeting Biological Drugs Sales Quantity by Region (2027-2032) & (K Units)
Table 55. Global IL-17 Targeting Biological Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 56. Global IL-17 Targeting Biological Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 57. Global IL-17 Targeting Biological Drugs Average Price by Region (2021-2026) & (US$/Unit)
Table 58. Global IL-17 Targeting Biological Drugs Average Price by Region (2027-2032) & (US$/Unit)
Table 59. Global IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 60. Global IL-17 Targeting Biological Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 61. Global IL-17 Targeting Biological Drugs Consumption Value by Type (2021-2026) & (USD Million)
Table 62. Global IL-17 Targeting Biological Drugs Consumption Value by Type (2027-2032) & (USD Million)
Table 63. Global IL-17 Targeting Biological Drugs Average Price by Type (2021-2026) & (US$/Unit)
Table 64. Global IL-17 Targeting Biological Drugs Average Price by Type (2027-2032) & (US$/Unit)
Table 65. Global IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 66. Global IL-17 Targeting Biological Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 67. Global IL-17 Targeting Biological Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 68. Global IL-17 Targeting Biological Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 69. Global IL-17 Targeting Biological Drugs Average Price by Application (2021-2026) & (US$/Unit)
Table 70. Global IL-17 Targeting Biological Drugs Average Price by Application (2027-2032) & (US$/Unit)
Table 71. North America IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 72. North America IL-17 Targeting Biological Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 73. North America IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 74. North America IL-17 Targeting Biological Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 75. North America IL-17 Targeting Biological Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 76. North America IL-17 Targeting Biological Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 77. North America IL-17 Targeting Biological Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 78. North America IL-17 Targeting Biological Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 79. Europe IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 80. Europe IL-17 Targeting Biological Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 81. Europe IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 82. Europe IL-17 Targeting Biological Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 83. Europe IL-17 Targeting Biological Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 84. Europe IL-17 Targeting Biological Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 85. Europe IL-17 Targeting Biological Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 86. Europe IL-17 Targeting Biological Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 87. Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 88. Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 89. Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 90. Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 91. Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity by Region (2021-2026) & (K Units)
Table 92. Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity by Region (2027-2032) & (K Units)
Table 93. Asia-Pacific IL-17 Targeting Biological Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific IL-17 Targeting Biological Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 95. South America IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 96. South America IL-17 Targeting Biological Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 97. South America IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 98. South America IL-17 Targeting Biological Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 99. South America IL-17 Targeting Biological Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 100. South America IL-17 Targeting Biological Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 101. South America IL-17 Targeting Biological Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 102. South America IL-17 Targeting Biological Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 103. Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 104. Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 105. Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 106. Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 107. Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 108. Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 109. Middle East & Africa IL-17 Targeting Biological Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa IL-17 Targeting Biological Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 111. IL-17 Targeting Biological Drugs Raw Material
Table 112. Key Manufacturers of IL-17 Targeting Biological Drugs Raw Materials
Table 113. IL-17 Targeting Biological Drugs Typical Distributors
Table 114. IL-17 Targeting Biological Drugs Typical Customers
Table 1. Global IL-17 Targeting Biological Drugs Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global IL-17 Targeting Biological Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Chongqing Genrix Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Chongqing Genrix Biopharmaceutical Major Business
Table 5. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product and Services
Table 6. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Chongqing Genrix Biopharmaceutical Recent Developments/Updates
Table 8. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 9. Jiangsu Hengrui Medicine Major Business
Table 10. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product and Services
Table 11. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis IL-17 Targeting Biological Drugs Product and Services
Table 16. Novartis IL-17 Targeting Biological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Novartis Recent Developments/Updates
Table 18. UCB Basic Information, Manufacturing Base and Competitors
Table 19. UCB Major Business
Table 20. UCB IL-17 Targeting Biological Drugs Product and Services
Table 21. UCB IL-17 Targeting Biological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. UCB Recent Developments/Updates
Table 23. Eli Lilly and Co. Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly and Co. Major Business
Table 25. Eli Lilly and Co. IL-17 Targeting Biological Drugs Product and Services
Table 26. Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Eli Lilly and Co. Recent Developments/Updates
Table 28. Akesobio Basic Information, Manufacturing Base and Competitors
Table 29. Akesobio Major Business
Table 30. Akesobio IL-17 Targeting Biological Drugs Product and Services
Table 31. Akesobio IL-17 Targeting Biological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Akesobio Recent Developments/Updates
Table 33. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 34. AstraZeneca Major Business
Table 35. AstraZeneca IL-17 Targeting Biological Drugs Product and Services
Table 36. AstraZeneca IL-17 Targeting Biological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. AstraZeneca Recent Developments/Updates
Table 38. DICE Therapeutics Basic Information, Manufacturing Base and Competitors
Table 39. DICE Therapeutics Major Business
Table 40. DICE Therapeutics IL-17 Targeting Biological Drugs Product and Services
Table 41. DICE Therapeutics IL-17 Targeting Biological Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. DICE Therapeutics Recent Developments/Updates
Table 43. Global IL-17 Targeting Biological Drugs Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 44. Global IL-17 Targeting Biological Drugs Revenue by Manufacturer (2021-2026) & (USD Million)
Table 45. Global IL-17 Targeting Biological Drugs Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 46. Market Position of Manufacturers in IL-17 Targeting Biological Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 47. Head Office and IL-17 Targeting Biological Drugs Production Site of Key Manufacturer
Table 48. IL-17 Targeting Biological Drugs Market: Company Product Type Footprint
Table 49. IL-17 Targeting Biological Drugs Market: Company Product Application Footprint
Table 50. IL-17 Targeting Biological Drugs New Market Entrants and Barriers to Market Entry
Table 51. IL-17 Targeting Biological Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global IL-17 Targeting Biological Drugs Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 53. Global IL-17 Targeting Biological Drugs Sales Quantity by Region (2021-2026) & (K Units)
Table 54. Global IL-17 Targeting Biological Drugs Sales Quantity by Region (2027-2032) & (K Units)
Table 55. Global IL-17 Targeting Biological Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 56. Global IL-17 Targeting Biological Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 57. Global IL-17 Targeting Biological Drugs Average Price by Region (2021-2026) & (US$/Unit)
Table 58. Global IL-17 Targeting Biological Drugs Average Price by Region (2027-2032) & (US$/Unit)
Table 59. Global IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 60. Global IL-17 Targeting Biological Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 61. Global IL-17 Targeting Biological Drugs Consumption Value by Type (2021-2026) & (USD Million)
Table 62. Global IL-17 Targeting Biological Drugs Consumption Value by Type (2027-2032) & (USD Million)
Table 63. Global IL-17 Targeting Biological Drugs Average Price by Type (2021-2026) & (US$/Unit)
Table 64. Global IL-17 Targeting Biological Drugs Average Price by Type (2027-2032) & (US$/Unit)
Table 65. Global IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 66. Global IL-17 Targeting Biological Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 67. Global IL-17 Targeting Biological Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 68. Global IL-17 Targeting Biological Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 69. Global IL-17 Targeting Biological Drugs Average Price by Application (2021-2026) & (US$/Unit)
Table 70. Global IL-17 Targeting Biological Drugs Average Price by Application (2027-2032) & (US$/Unit)
Table 71. North America IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 72. North America IL-17 Targeting Biological Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 73. North America IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 74. North America IL-17 Targeting Biological Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 75. North America IL-17 Targeting Biological Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 76. North America IL-17 Targeting Biological Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 77. North America IL-17 Targeting Biological Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 78. North America IL-17 Targeting Biological Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 79. Europe IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 80. Europe IL-17 Targeting Biological Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 81. Europe IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 82. Europe IL-17 Targeting Biological Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 83. Europe IL-17 Targeting Biological Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 84. Europe IL-17 Targeting Biological Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 85. Europe IL-17 Targeting Biological Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 86. Europe IL-17 Targeting Biological Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 87. Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 88. Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 89. Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 90. Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 91. Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity by Region (2021-2026) & (K Units)
Table 92. Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity by Region (2027-2032) & (K Units)
Table 93. Asia-Pacific IL-17 Targeting Biological Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific IL-17 Targeting Biological Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 95. South America IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 96. South America IL-17 Targeting Biological Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 97. South America IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 98. South America IL-17 Targeting Biological Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 99. South America IL-17 Targeting Biological Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 100. South America IL-17 Targeting Biological Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 101. South America IL-17 Targeting Biological Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 102. South America IL-17 Targeting Biological Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 103. Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity by Type (2021-2026) & (K Units)
Table 104. Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity by Type (2027-2032) & (K Units)
Table 105. Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity by Application (2021-2026) & (K Units)
Table 106. Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity by Application (2027-2032) & (K Units)
Table 107. Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity by Country (2021-2026) & (K Units)
Table 108. Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity by Country (2027-2032) & (K Units)
Table 109. Middle East & Africa IL-17 Targeting Biological Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa IL-17 Targeting Biological Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 111. IL-17 Targeting Biological Drugs Raw Material
Table 112. Key Manufacturers of IL-17 Targeting Biological Drugs Raw Materials
Table 113. IL-17 Targeting Biological Drugs Typical Distributors
Table 114. IL-17 Targeting Biological Drugs Typical Customers
LIST OF FIGURES
Figure 1. IL-17 Targeting Biological Drugs Picture
Figure 2. Global IL-17 Targeting Biological Drugs Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global IL-17 Targeting Biological Drugs Revenue Market Share by Type in 2025
Figure 4. Oral Examples
Figure 5. Injection Examples
Figure 6. Global IL-17 Targeting Biological Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application in 2025
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Other Examples
Figure 11. Global IL-17 Targeting Biological Drugs Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global IL-17 Targeting Biological Drugs Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global IL-17 Targeting Biological Drugs Sales Quantity (2021-2032) & (K Units)
Figure 14. Global IL-17 Targeting Biological Drugs Price (2021-2032) & (US$/Unit)
Figure 15. Global IL-17 Targeting Biological Drugs Sales Quantity Market Share by Manufacturer in 2025
Figure 16. Global IL-17 Targeting Biological Drugs Revenue Market Share by Manufacturer in 2025
Figure 17. Producer Shipments of IL-17 Targeting Biological Drugs by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 18. Top 3 IL-17 Targeting Biological Drugs Manufacturer (Revenue) Market Share in 2025
Figure 19. Top 6 IL-17 Targeting Biological Drugs Manufacturer (Revenue) Market Share in 2025
Figure 20. Global IL-17 Targeting Biological Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 21. Global IL-17 Targeting Biological Drugs Consumption Value Market Share by Region (2021-2032)
Figure 22. North America IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 23. Europe IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 24. Asia-Pacific IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 25. South America IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 26. Middle East & Africa IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 27. Global IL-17 Targeting Biological Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 28. Global IL-17 Targeting Biological Drugs Consumption Value Market Share by Type (2021-2032)
Figure 29. Global IL-17 Targeting Biological Drugs Average Price by Type (2021-2032) & (US$/Unit)
Figure 30. Global IL-17 Targeting Biological Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 31. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2021-2032)
Figure 32. Global IL-17 Targeting Biological Drugs Average Price by Application (2021-2032) & (US$/Unit)
Figure 33. North America IL-17 Targeting Biological Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 34. North America IL-17 Targeting Biological Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 35. North America IL-17 Targeting Biological Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 36. North America IL-17 Targeting Biological Drugs Consumption Value Market Share by Country (2021-2032)
Figure 37. United States IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe IL-17 Targeting Biological Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 41. Europe IL-17 Targeting Biological Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 42. Europe IL-17 Targeting Biological Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 43. Europe IL-17 Targeting Biological Drugs Consumption Value Market Share by Country (2021-2032)
Figure 44. Germany IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 45. France IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 46. United Kingdom IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 47. Russia IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 48. Italy IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 49. Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 50. Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 51. Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 52. Asia-Pacific IL-17 Targeting Biological Drugs Consumption Value Market Share by Region (2021-2032)
Figure 53. China IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 54. Japan IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 55. South Korea IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 56. India IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 57. Southeast Asia IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 58. Australia IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 59. South America IL-17 Targeting Biological Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 60. South America IL-17 Targeting Biological Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 61. South America IL-17 Targeting Biological Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 62. South America IL-17 Targeting Biological Drugs Consumption Value Market Share by Country (2021-2032)
Figure 63. Brazil IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 64. Argentina IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 65. Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 66. Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 67. Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 68. Middle East & Africa IL-17 Targeting Biological Drugs Consumption Value Market Share by Country (2021-2032)
Figure 69. Turkey IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 70. Egypt IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 71. Saudi Arabia IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 72. South Africa IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 73. IL-17 Targeting Biological Drugs Market Drivers
Figure 74. IL-17 Targeting Biological Drugs Market Restraints
Figure 75. IL-17 Targeting Biological Drugs Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of IL-17 Targeting Biological Drugs in 2025
Figure 78. Manufacturing Process Analysis of IL-17 Targeting Biological Drugs
Figure 79. IL-17 Targeting Biological Drugs Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. IL-17 Targeting Biological Drugs Picture
Figure 2. Global IL-17 Targeting Biological Drugs Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global IL-17 Targeting Biological Drugs Revenue Market Share by Type in 2025
Figure 4. Oral Examples
Figure 5. Injection Examples
Figure 6. Global IL-17 Targeting Biological Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application in 2025
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Other Examples
Figure 11. Global IL-17 Targeting Biological Drugs Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global IL-17 Targeting Biological Drugs Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global IL-17 Targeting Biological Drugs Sales Quantity (2021-2032) & (K Units)
Figure 14. Global IL-17 Targeting Biological Drugs Price (2021-2032) & (US$/Unit)
Figure 15. Global IL-17 Targeting Biological Drugs Sales Quantity Market Share by Manufacturer in 2025
Figure 16. Global IL-17 Targeting Biological Drugs Revenue Market Share by Manufacturer in 2025
Figure 17. Producer Shipments of IL-17 Targeting Biological Drugs by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 18. Top 3 IL-17 Targeting Biological Drugs Manufacturer (Revenue) Market Share in 2025
Figure 19. Top 6 IL-17 Targeting Biological Drugs Manufacturer (Revenue) Market Share in 2025
Figure 20. Global IL-17 Targeting Biological Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 21. Global IL-17 Targeting Biological Drugs Consumption Value Market Share by Region (2021-2032)
Figure 22. North America IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 23. Europe IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 24. Asia-Pacific IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 25. South America IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 26. Middle East & Africa IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 27. Global IL-17 Targeting Biological Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 28. Global IL-17 Targeting Biological Drugs Consumption Value Market Share by Type (2021-2032)
Figure 29. Global IL-17 Targeting Biological Drugs Average Price by Type (2021-2032) & (US$/Unit)
Figure 30. Global IL-17 Targeting Biological Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 31. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2021-2032)
Figure 32. Global IL-17 Targeting Biological Drugs Average Price by Application (2021-2032) & (US$/Unit)
Figure 33. North America IL-17 Targeting Biological Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 34. North America IL-17 Targeting Biological Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 35. North America IL-17 Targeting Biological Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 36. North America IL-17 Targeting Biological Drugs Consumption Value Market Share by Country (2021-2032)
Figure 37. United States IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe IL-17 Targeting Biological Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 41. Europe IL-17 Targeting Biological Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 42. Europe IL-17 Targeting Biological Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 43. Europe IL-17 Targeting Biological Drugs Consumption Value Market Share by Country (2021-2032)
Figure 44. Germany IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 45. France IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 46. United Kingdom IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 47. Russia IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 48. Italy IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 49. Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 50. Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 51. Asia-Pacific IL-17 Targeting Biological Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 52. Asia-Pacific IL-17 Targeting Biological Drugs Consumption Value Market Share by Region (2021-2032)
Figure 53. China IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 54. Japan IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 55. South Korea IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 56. India IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 57. Southeast Asia IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 58. Australia IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 59. South America IL-17 Targeting Biological Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 60. South America IL-17 Targeting Biological Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 61. South America IL-17 Targeting Biological Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 62. South America IL-17 Targeting Biological Drugs Consumption Value Market Share by Country (2021-2032)
Figure 63. Brazil IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 64. Argentina IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 65. Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 66. Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 67. Middle East & Africa IL-17 Targeting Biological Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 68. Middle East & Africa IL-17 Targeting Biological Drugs Consumption Value Market Share by Country (2021-2032)
Figure 69. Turkey IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 70. Egypt IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 71. Saudi Arabia IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 72. South Africa IL-17 Targeting Biological Drugs Consumption Value (2021-2032) & (USD Million)
Figure 73. IL-17 Targeting Biological Drugs Market Drivers
Figure 74. IL-17 Targeting Biological Drugs Market Restraints
Figure 75. IL-17 Targeting Biological Drugs Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of IL-17 Targeting Biological Drugs in 2025
Figure 78. Manufacturing Process Analysis of IL-17 Targeting Biological Drugs
Figure 79. IL-17 Targeting Biological Drugs Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
